Caterna develops digital therapies for the treatment of eye diseases. The first product is Caterna Vision Therapy, an on-screen application that is to be used as an adjunct to occlusion treatment of amblyopia. Caterna Vision Therapy is Europe's first Internet-based therapy to be reimbursed by statutory health insurance.
Amblyopia is a functional disorder that usually results from strabismus (squinting). It leads to severe visual impairment of the affected eye. This is caused by a processing disfunction in the brain, because of which the eye has“ forgotten” how to see. Eye-training exercises can have a positive effect on such manifestations.
Caterna Vision Therapy is performed under medical guidance and can only be prescribed by an ophthalmologist. After diagnosis and consultation, the ophthalmologist will determine the type duration of the child’s vision exercises. Once treatment has been initiated, Caterna Vision Therapy is continued at home. The therapy is easy to use and can be integrated into the daily routine of the child’s family life. For the first time, the ophthalmologist can track progress of the treatment online because each exercise session is recorded automatically. Moreover, the occlusion time recording function enables parents to monitor their child´s progress. It can be accessed via smartphone, tablet or regular PC.
The Caterna Vision Therapy program is a certified therapeutic medical product and carries a CE mark as affirmation of conformity with the requirements set out in Annex 1 of the European Medical Device Directive 93/42/EWG. As the manufacturer, Caterna has thus committed itself to compliance with the established quality standards for medical devices.
Caterna Vision GmbH, Leipziger Straße 26, Berlin 10117 Berlin